fbpx

CooperVision Partners with Canadian Health & Family to Promote Awareness of the Myopia Epidemic

With myopia projected to impact 50% of the world’s population by 2050, CooperVision Canada has partnered with Canadian Health & Family to promote awareness of childhood myopia through an educational segment available to stream online at www.healthandfamily.ca/MyopiaEpidemic

The segment—which originally aired on television networks CTV and HGTV, and again last month on CTV Toronto and CTV Montreal—features Debbie Jones, BSc, FCOptom, FAAO, clinical professor at the University of Waterloo and clinical scientist at the Centre for Ocular Research & Education (CORE). Dr. Jones has been studying the effectiveness of the FDA-approved CooperVision MiSight® 1 day lens which has been shown to slow the progression of myopia in children by 59%. She was also involved in a study that examined myopia prevalence locally in Waterloo, Ontario and the surrounding area that revealed that 35% of study participants were living with uncorrected myopia. 

“At CooperVision, our goal is to elevate the standard of care such that no case of paediatric myopiagoes untreated,” said Alexandra Donkin, General Manager for CooperVision Canada. “Our partnership with Canadian Health & Family on this educational segment is one part of our work to get there. Parents, pediatricians, teachers and everyone in the life of a child need to be aware of the myopia epidemic and its impact. Only through awareness of the issue can a resolution towards slowing the progression be achieved.”

The segment also features the story of a young MiSight® 1 day clinical study participant, who shared how the freedom offered by contact lenses is a benefit for her active lifestyle, and a word from Joshua C. Smith, OD, past president of the Ontario Association of Optometrists, who emphasized the impact that time spent outdoors can have on reducing a child’s risk for developing myopia.

In addition to the television broadcast and online streaming, CooperVision has planned a digital advertising campaign featuring the segment, which will run in targeted markets through October.

Click HERE for the full press release.

Featured Posts

Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read More
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read More
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read More
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more